Finance R&D Intern
Ipsen Global
Finance R&D Intern
Ipsen Global
Global biopharma focused on specialty care
Title:
Stagiaire Finance R&DCompany:
Ipsen Pharma (SAS)About Ipsen:
Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.S., France and the U.K, we tackle areas of high unmet medical need through research and innovation.
Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human-centric leadership and fosters a culture of collaboration, excellence and impact. At Ipsen, every individual is empowered to be their true selves, grow and thrive alongside the company’s success. Join us on our journey towards sustainable growth, creating real impact on patients and society!
For more information, visit us at https://www.ipsen.com/ and follow our latest news on LinkedIn and Instagram.
Job Description:
Type de contrat : Stage
Durée : 6 mois
Date de début : À partir de décembre 2026 ou janvier 202
As part of the R&D Finance team, the intern supports the financial management of R&D activities and development programs. The role contributes to month-end closing, reporting, forecasting, budgeting and long-range planning, while helping Finance Business Partners and operational teams monitor costs, commitments and financial performance.
Part of the R&D Finance Team:
Knowledge & Experience (essential):
Knowledge & Experience (preferred):
Education / Certifications (preferred):
Language(s) (essential):
Global biopharma focused on specialty care
Ipsen is a global biopharmaceutical company that concentrates on specialty care, developing and marketing medicines for oncology, neuroscience, and rare diseases. Its products work by treating specific high-need conditions, ranging from historical diarrhea treatment Smecta to modern targeted therapies in cancer and neurological disorders. The company differentiates itself through a focused portfolio in niche therapeutic areas, growth via strategic acquisitions, and a long-standing family heritage that shaped its international expansion and IPO-driven capital for expansion. Its goal is to address unmet medical needs worldwide by providing effective therapies for patients with serious or rare conditions.
Explore more opportunities at Ipsen Global